4.7 Article

Telomere length and hTERT genetic variants as potential prognostic markers in multiple myeloma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Relationship between Telomere Length, TERT Genetic Variability and TERT, TP53, SP1, MYC Gene Co-Expression in the Clinicopathological Profile of Breast Cancer

Marta Dratwa et al.

Summary: This study investigated the molecular mechanisms of TERT upregulation in breast cancer, including genetic variability and telomere length, as well as the expression of TERT, MYC, TP53, and SP1 genes in BC patients and BC organoids. Results showed correlations between TERT genotypes, TP53 expression, and telomere length, suggesting TERT genetic variability may serve as potential biomarkers for breast cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia

Marta Dratwa et al.

Summary: The study suggests that telomere length and TERT gene polymorphisms may impact the risk and overall survival of AML patients. AML patients have shorter telomeres compared to healthy controls, and FLT3-ITD mutation may independently affect telomere length. Additionally, AML patients with the TERT rs2853669 CC genotype have significantly shorter overall survival.

SCIENTIFIC REPORTS (2021)

Review Oncology

Genome Instability in Multiple Myeloma: Facts and Factors

Anna Y. Aksenova et al.

Summary: Multiple myeloma is an incurable blood cancer characterized by genetic changes affecting various cellular pathways. The disease is complex and heterogeneous, with genome instability playing a pivotal role in understanding its causes and developing new therapies. Chemotherapeutic agents used to treat multiple myeloma exacerbate genome instability, adding another layer of complexity to the disease.

CANCERS (2021)

Article Oncology

Telomere Architecture Correlates with Aggressiveness in Multiple Myeloma

Aline Rangel-Pozzo et al.

Summary: Multiple myeloma (MM) is an incurable blood cancer with diverse disease courses and outcomes among patients. The scientific and medical communities are focusing on risk assessment and personalized treatment management for each MM patient, as specific telomeric profiles have been associated with disease aggressiveness and patient response to treatment.

CANCERS (2021)

Review Biochemistry & Molecular Biology

The TERT rs2736100 Polymorphism and Susceptibility to Myeloproliferative Neoplasms: A Systematic Review and Meta-Analysis

Tao Hong et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS (2020)

Review Immunology

TERT-Regulation and Roles in Cancer Formation

Marta Dratwa et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, Research & Experimental

Telomere Length and Hematological Disorders: A Review

Beatriz Maria Dias Nogueira et al.

IN VIVO (2020)

Article Biotechnology & Applied Microbiology

Variability within the human TERT gene, telomere length and predisposition to chronic lymphocytic leukemia

Barbara Wysoczanska et al.

ONCOTARGETS AND THERAPY (2019)

Article Oncology

Telomere length in peripheral blood leukocytes and risk of renal cell carcinoma

Jong Y. Park et al.

TRANSLATIONAL CANCER RESEARCH (2019)

Article Genetics & Heredity

TERT rs10069690 polymorphism and cancers risk: A meta-analysis

Guisheng He et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2019)

Article Genetics & Heredity

Genome-wide association study of telomere length among South Asians identifies a second RTEL1 association signal

Dayana A. Delgado et al.

JOURNAL OF MEDICAL GENETICS (2018)

Review Multidisciplinary Sciences

A regulatory loop connecting WNT signaling and telomere capping: possible therapeutic implications for dyskeratosis congenita

Rafael Jesus Fernandez et al.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2018)

Article Biochemistry & Molecular Biology

C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis

Jing Yang et al.

SCIENCE SIGNALING (2017)

Article Biochemistry & Molecular Biology

C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis

Jing Yang et al.

SCIENCE SIGNALING (2017)

Review Hematology

Maintenance of telomere length in AML

Peter M. Lansdorp

BLOOD ADVANCES (2017)

Article Hematology

Telomere length is a critical determinant for survival in multiple myeloma

Sam Hyatt et al.

BRITISH JOURNAL OF HAEMATOLOGY (2017)

Review Biochemistry & Molecular Biology

Reactivation of telomerase in cancer

Semih Can Akincilar et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

Review Hematology

Telomerase in hematologic malignancies

Claudia Bruedigam et al.

CURRENT OPINION IN HEMATOLOGY (2016)

Article Biochemistry & Molecular Biology

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Mitchell J. Machiela et al.

HUMAN MOLECULAR GENETICS (2016)

Review Oncology

Novel agents in the treatment of multiple myeloma: a review about the future

Leonard Naymagon et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)

Review Genetics & Heredity

Telomerase Activation in Hematological Malignancies

Joana Ropio et al.

GENES (2016)

Article Oncology

Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients

Yibing Chen et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)

Correction Genetics & Heredity

The telomere syndromes (vol 13, pg 693, 2012)

Mary Armanios et al.

NATURE REVIEWS GENETICS (2013)

Article Oncology

Three-dimensional Nuclear Telomere Organization in Multiple Myeloma

Ludger Klewes et al.

TRANSLATIONAL ONCOLOGY (2013)

Article Oncology

Telomere Length and Genetic Variation in Telomere Maintenance Genes in Relation to Ovarian Cancer Risk

Kathryn L. Terry et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)

Review Oncology

Telomerase Reverse Transcriptase Locus Polymorphisms and Cancer Risk: A Field Synopsis and Meta-Analysis

Simone Mocellin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Article Medicine, General & Internal

Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia

Phillip Scheinberg et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Genetics & Heredity

Genome-wide association study of hematological and biochemical traits in a Japanese population

Yoichiro Kamatani et al.

NATURE GENETICS (2010)

Article Biochemistry & Molecular Biology

ESPERR: Learning strong and weak signals in genomic sequence alignments to identify functional elements

James Taylor et al.

GENOME RESEARCH (2006)

Article Biochemistry & Molecular Biology

Telomere length of normal leukocytes is affected by a functional polymorphism of hTERT

Y Matsubara et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Medicine, General & Internal

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

H Yamaguchi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biochemical Research Methods

Haploview: analysis and visualization of LD and haplotype maps

JC Barrett et al.

BIOINFORMATICS (2005)

Article Hematology

Telomere shortening in patients with plasma cell disorders

A Cottliar et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2003)